Literature DB >> 16562058

Mode of Action of the Antiviral Activity of Amantadine in Tissue Culture.

C E Hoffmann1, E M Neumayer, R F Haff, R A Goldsby.   

Abstract

Hoffmann, C. E. (E. I. du Pont de Nemours & Co., Inc., Wilmington, Del.), E. M. Neumayer, R. F. Haff, and R. A. Goldsby. Mode of action of the antiviral activity of amantadine in tissue culture. J. Bacteriol. 90:623-628. 1965.-Amantadine hydrochloride has shown antiviral activity in tissue culture, in ovo, and in vivo. Experiments with it during the course of virus proliferation indicate that its antiviral activity is due to inhibition of virus penetration into the host cell. These studies indicate that amantadine hydrochloride is not virucidal at concentrations active in tissue culture. It does not block virus adsorption to host cells, nor does it affect the virus enzyme neuraminidase. In the presence of amantadine hydrochloride, virus adsorbed to susceptible cells remains at the cell surface in an infective state. An attempt to demonstrate high development of resistance to the antiviral action of amantadine hydrochloride in tissue culture has been unsuccessful.

Entities:  

Year:  1965        PMID: 16562058      PMCID: PMC315701          DOI: 10.1128/jb.90.3.623-628.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  3 in total

1.  THE IN VIVO ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). I. PROPHYLACTIC AND THERAPEUTIC ACTIVITY AGAINST INFLUENZA VIRUSES.

Authors:  R R GRUNERT; J W MCGAHEN; W L DAVIES
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

2.  RUBELLA VIRUS: INHIBITION IN VITRO BY AMANTADINE HYDROCHLORIDE.

Authors:  H F MAASSAB; K W COCHRAN
Journal:  Science       Date:  1964-09-25       Impact factor: 47.728

3.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

  3 in total
  24 in total

1.  Early events in myxovirus replication: immunofluorescent spots.

Authors:  O Haller; A Bucher-Nurminen; J Lindenmann
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

Review 2.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 3.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

4.  Adamantanamine and early events following influenza virus infection.

Authors:  W F Long; J Olusanya
Journal:  Arch Gesamte Virusforsch       Date:  1972

5.  Studies on the role of myxovirus neuraminidase in virus-cell receptor interaction by means of direct determination of sialic acid split from cells. 3. One-step growth kinetics of accumulation of the sialic acid liberated from NDV-infected chick embryo cells.

Authors:  I V Tsvetkova; M A Lipkind
Journal:  Arch Gesamte Virusforsch       Date:  1973

6.  Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial.

Authors:  N Oker-Blom; T Hovi; P Leinikki; T Palosuo; R Pettersson; J Suni
Journal:  Br Med J       Date:  1970-09-19

7.  Administration of amantadine for the prevention of Hong Kong influenza.

Authors:  I Nafta; A G TTurcanu; I Braun; W Companetz; A Simionescu; E Birţ; V Florea
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

8.  The inhibitory activity of an isoquinoline derivative on growth of an influenza A virus in tissue culture.

Authors:  D Hobson; H I Flockton; M G Gregory
Journal:  Br J Exp Pathol       Date:  1969-10

9.  Inhibition of in vitro proliferative responses of human lymphocytes by rimantadine hydrochloride.

Authors:  W C Koff; D L Peavy; V Knight
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.

Authors:  Giulia Muratore; Beatrice Mercorelli; Laura Goracci; Gabriele Cruciani; Paul Digard; Giorgio Palù; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.